Reported Pregnancy Outcomes in Women With Severe Atopic Dermatitis Treated With Dupilumab: A Systematic Review

J Cutan Med Surg. 2023 Mar-Apr;27(2):177-178. doi: 10.1177/12034754231152223. Epub 2023 Jan 31.

Authors

Edgar Akuffo-Addo¹, Mathew N Nicholas², Perla Lansang²

Affiliations

¹ 12366 Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
² 12366 Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

PMID: 36721993
DOI: 10.1177/12034754231152223

No abstract available

Keywords: atopic dermatitis; dupilumab; pregnant; systematic review.

Publication types

Systematic Review
Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Dermatitis, Atopic* / drug therapy
Female
Humans
Pregnancy
Pregnancy Outcome
Severity of Illness Index
Treatment Outcome

Substances

dupilumab
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal